ClinicalTrials.gg
CompletedNCT07942506Updated Nov 17, 2026

The Effect of Health Education Conducted Using Two Different Methods on Individuals in a High-risk Age Group Regarding Their Health Beliefs and Attitudes Towards Colorectal Cancer Screening, and Their Participation in the Screening Program

An interventional study of Health Education Group and Motivational Interviewing group in Colorectal Cancer Screening, sponsored by Saglik Bilimleri Universitesi Gulhane Tip Fakultesi. Completed at 2 sites in Turkey (Türkiye). Open to participants aged 50 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Saglik Bilimleri Universitesi Gulhane Tip Fakultesi · Not applicable, Interventional, and Other

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
50 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 90 studies in Colorectal Neoplasms with a site in Turkey — 20 open to participants now, 21 under way, 5 of them phase 3. Colorectal Neoplasms · Turkey.

Enrollment
32nd of 65
120 · median 116
Started
2026
with 6 others
No phase
35 of 90
6 open now
Registered
90th of 90
by date

Among the 90 studies in Colorectal Neoplasms with a site in Turkey, this one is the 32nd largest by enrollment of the 65 interventional ones that give a count, is one of 7 that started in 2026, is one of 35 with no phase, and was the 90th registered.

Colorectal Neoplasms

6,552 studies on the registry are indexed under Colorectal Neoplasms; 1,664 are open to participants now.

Browse Colorectal Neoplasms studies →

Open to participants now

20 of the 90 studies in Colorectal Neoplasms with a site in Turkey are open now. Recruiting first, the newest first:

15 more — sign in →

All 20 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 1,178 Colorectal Neoplasms studies recruiting now, 761 (65%) set no upper age limit and 264 (22%) stop at 75 or younger; 48 take children under 18; 123 take healthy volunteers.

This study: 50 Years to 70 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 90 studies in Colorectal Neoplasms with a site in Turkey, or all of them as a file.
02

Study summary

Colorectal cancer is the third most common type of cancer worldwide and can be fatal if not diagnosed early. Screening tests, such as the fecal occult blood test, help detect colorectal cancer at an early stage, which increases the chances of successful treatment. However, many people do not undergo regular screenings due to fear, a lack of information, or other barriers. This study examines two different methods used to inform individuals aged 50-70 about colorectal cancer screening: traditional health education and a counseling approach known as "motivational interviewing." Motivational interviewing helps individuals feel more confident and willing to undergo screening by encouraging them to talk about their concerns and guiding them toward making positive decisions. The aim of the study is to determine which method is more effective in improving individuals' health-related beliefs and attitudes regarding colorectal cancer, as well as their actual participation in screening programs. The findings will help us enhance the support we provide to individuals in safeguarding their health.

Read the detailed description

Cancer is a chronic disease characterized by uncontrolled cell proliferation, which impairs health by affecting the functions of tissues, organs, and bodily systems, and leads to morbidity and mortality. Globally, approximately 10 million deaths occur each year-meaning one in every six deaths is directly attributable to cancer-making it the second leading cause of death overall. According to reports from international authorities for 2022, colorectal cancer (CRC) is the second most common cause of cancer-related deaths. In 2022, approximately 1.9 million new cases of CRC were diagnosed worldwide, resulting in nearly one million deaths. Projections indicate that by 2045, the incidence of CRC will increase by 70%, with the total number of cases rising to 3.29 million; meanwhile, CRC-related mortality is expected to climb by 83%, reaching a total of 1.66 million deaths per year. In Turkey, CRC is the third most common type of cancer and ranks among the primary cancers responsible for more than 10,000 deaths annually.

Colorectal cancer is a significant and priority public health issue; it is prevalent, frequently leads to disability and death, and exerts a negative impact on the health of individuals, families, and society-encompassing biopsychosocial and economic dimensions. At the individual and family levels, CRC impairs physical, psychological, and social well-being, while also placing a strain on family finances. From a societal perspective, CRC imposes a substantial burden on the national economy by significantly increasing the utilization of healthcare services, driving up treatment and care costs, and resulting in reduced productivity and losses in the workforce. Studies indicate that various genetic, biological, behavioral, and environmental factors-such as family history, lifestyle habits, and chronic intestinal inflammation-serve as risk factors for the development of CRC.

Although the colorectal cancer (CRC) screening program in our country is easy to access and free of charge for high-risk groups, participation rates remain low. The literature identifies several reasons for this, including a lack of knowledge about screening programs and cancer symptoms, a low perception of risk, the absence of current physical complaints, feelings of embarrassment, a lack of time, insufficient information provided by healthcare personnel, a lack of motivation, and negative attitudes or beliefs regarding screening. Given the complexity of the factors that determine whether an individual participates in screening, it is essential to examine the health beliefs of those at risk. Health beliefs are among the most fundamental factors shaping an individual's health-related behaviors. To improve participation in screening among individuals in high-risk age groups, it is recommended that the factors influencing these behaviors be identified and positively reinforced. Nurses play a significant role and bear a major responsibility in identifying the specific health beliefs that influence participation in the CRC screening program.

Motivation is an internal state-influenced by external factors-that signifies a readiness for change; it is a client-centered approach. The objective here is to enhance an individual's intrinsic motivation to facilitate action. A review of the existing literature reveals a limited number of studies in our country that utilize standard health education or motivational interviewing-based health education to increase participation in national cancer screening programs. Furthermore, there are no studies that employ motivational interviewing and the Health Belief Model (HBM) to examine the impact on health beliefs, attitudes, and participation regarding colorectal cancer (CRC) screening programs. The health education and counseling intervention in this study is grounded in the theoretical framework of the Health Belief Model. Accordingly, the intervention content is designed to encompass the following components: perceived susceptibility, perceived severity, perceived benefits, perceived barriers, and perceived self-efficacy. The intervention aims to increase participants' perceived susceptibility to developing CRC, as well as their perception of the severity of the potential health consequences should they develop the disease. Additionally, the intervention seeks to strengthen participants' perceptions of the benefits-specifically, the protective effect of early detection and treatment of CRC through regular screening-while simultaneously reducing perceived barriers to participation and enhancing self-efficacy regarding their capacity to undergo the necessary screening procedures. It is anticipated that the health education intervention, developed based on this theoretical foundation, will bring about positive changes in the participants' health beliefs and attitudes regarding their regular participation in the colorectal cancer (CRC) screening program.

03

Conditions studied

  • Colorectal Cancer Screening

Keywords

  • Colorectal Cancer, Colorectal Cancer Screening, Motivational Interviewing, Health Education
  • Fecal Occult Blood, Colonoscopy
04

Who can participate

Ages eligible
50 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: Being willing to participate in the research, Being between the ages of 50 and 70, Having completed at least primary education, Scoring 24 or higher on the Standardized (for individuals over the age of 65), Being registered at the Family Health Center where the study is conducted, Being an active user of the WhatsApp application on one's mobile phone

Exclusion Criteria: Having a diagnosed bowel disease (such as inflammatory bowel disease, Crohn's disease, ulcerative colitis, etc.), Having a history of colorectal cancer in first-degree relatives, Being a healthcare professional, Having undergone colorectal cancer screening within the last two years, Having a condition that hinders verbal or written communication, Having an orthopedic impairment that prevents the completion of questionnaires, Having a mental health disorder or condition, Residing in a nursing home or other social care institution, Having previously received education regarding colorectal cancer screening.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    Health Education Group

    Arm Description: Participants will be involved in structured educational sessions focused on increasing their knowledge about colorectal cancer, its risk factors, and the importance of early screening.

    Behavioral: Health Education Group

  • Experimental
    Motivational Interviewing Group

    Participants will take part in one-on-one counseling sessions that utilize motivational interviewing techniques, with the aim of increasing motivation and reducing barriers to colorectal cancer screening.

    Behavioral: Motivational Interviewing group

  • No intervention
    Control Group

    Participants will not receive any intervention during the study period.

Interventions

  • BehavioralHealth Education Group

    Structured group education focusing on colorectal cancer awareness, risk reduction, and early detection.

  • BehavioralMotivational Interviewing group

    Individual counseling sessions using motivational interviewing to enhance screening behavior.

06

What researchers measure

Primary outcomes

  1. 1. Participation Rate in Colorectal Cancer Screening

    The proportion of individuals who undergo colorectal cancer screening within 1 months following the educational/motivational interviewing intervention; this will be assessed using health records and surveys.

    Time frame: Baseline and 1 month after intervention

07

Study locations

2 sites
  • Elife Mehmet Kahraman Family Health Center, Ankara, Yenimahalle
    Ankara, Etlik 06018, Turkey (Türkiye)
  • Elife Mehmet Kahraman Family Health Center, Ankara, Yenimahalle
    Ankara, Yenimahalle 06200, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2026 to primary completion in Nov 2026, 0 months.

Of 900 non-industry interventional studies with no phase under Colorectal Neoplasms, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 61. This study's 0 months is below that.

Counting every sponsor, half of 957 studies reached it within 31 months; a quarter within 14 and three quarters within 60.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 11, 2026
First posted
Nov 17, 2026
StartActual
Nov 1, 2026
Primary completionActual
Nov 10, 2026
CompletionActual
Nov 10, 2026
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07942506
Lead sponsor
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
Responsible party
Serpil Özdemir (Associate Professor, Saglik Bilimleri Universitesi Gulhane Tip Fakultesi) — Principal investigator
First posted
Nov 17, 2026
Start date
Nov 1, 2026
Primary completion
Nov 10, 2026
Completion
Nov 10, 2026
Last update
Nov 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion